Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jansen

Showing results (191-200 of 664) with videos related to

Pageof 67
Sort By:
European Journal of Pharmacology|July 7, 1992
The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: saturable and reversible binding to rat cortex membranesF P Jansen, B Rademaker, A Bast, et al.
Pharmacoeconomics|March 3, 2022
Assessments of the Value of New Interventions Should Include Health Equity ImpactJeroen P Jansen, Thomas A Trikalinos, Kathryn A Phillips
Oncogene|November 1, 2001
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7S Mazurek, W Zwerschke, P Jansen-Dürr, et al.
Oncogene|June 20, 1996
S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphataseD Spitkovsky, P Jansen-Dürr, E Karsenti, et al.
Blut|April 20, 1978
[Concentration of specific antibodies in commercially avaialable immunoglobulins (author's transl)]C H Wirsing, H Finger, P Jansen, et al.
Communications in Agricultural and Applied Biological Sciences|April 25, 2006
Selectivity lists of pesticides to beneficial arthropods for IPM programs in carrot--first resultsL Hautier, J-P Jansen, N Mabon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Differential activation of the E2F transcription factor by the adenovirus EIa and EIV products in F9 cellsH Boeuf, B Reimund, P Jansen-Durr, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2025
Combining simulation model-based outcomes with county-level data for geographic health equity impact evaluations of new interventionsJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Communications in Agricultural and Applied Biological Sciences|April 11, 2008
Influence of organic matter on bio-availability of carbosulfan and its toxicity on a carabid beetleL Hautier, J P Jansen, N Mabon, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 14, 1989
[Visit to the emergency department: primary or secondary character?]C L Creutzberg, P P Jansen, J W Merkelbach
Pageof 67

Showing results (191-200 of 664) with videos related to

Sort By:
Pageof 67
European Journal of Pharmacology|July 7, 1992
The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: saturable and reversible binding to rat cortex membranesF P Jansen, B Rademaker, A Bast, et al.
Pharmacoeconomics|March 3, 2022
Assessments of the Value of New Interventions Should Include Health Equity ImpactJeroen P Jansen, Thomas A Trikalinos, Kathryn A Phillips
Oncogene|November 1, 2001
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7S Mazurek, W Zwerschke, P Jansen-Dürr, et al.
Oncogene|June 20, 1996
S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphataseD Spitkovsky, P Jansen-Dürr, E Karsenti, et al.
Blut|April 20, 1978
[Concentration of specific antibodies in commercially avaialable immunoglobulins (author's transl)]C H Wirsing, H Finger, P Jansen, et al.
Communications in Agricultural and Applied Biological Sciences|April 25, 2006
Selectivity lists of pesticides to beneficial arthropods for IPM programs in carrot--first resultsL Hautier, J-P Jansen, N Mabon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Differential activation of the E2F transcription factor by the adenovirus EIa and EIV products in F9 cellsH Boeuf, B Reimund, P Jansen-Durr, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2025
Combining simulation model-based outcomes with county-level data for geographic health equity impact evaluations of new interventionsJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Communications in Agricultural and Applied Biological Sciences|April 11, 2008
Influence of organic matter on bio-availability of carbosulfan and its toxicity on a carabid beetleL Hautier, J P Jansen, N Mabon, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 14, 1989
[Visit to the emergency department: primary or secondary character?]C L Creutzberg, P P Jansen, J W Merkelbach
Pageof 67